Company: JACS-RI
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001213900-25-073677
Chunk: 3

Company: Jackson Acquisition Co II
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 1
Chunk 3
---
505 

The accompanying notes are an integral part of
the unaudited condensed financial statements.

3

JACKSON ACQUISITION COMPANY II

CONDENSED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2025

(UNAUDITED)

    Cash Flows from Operating Activities: 

    Net income 
    $4,545,737 
  
    Adjustments to reconcile net income to net cash used in operating activities: 

    Interest earned on marketable securities held in Trust Account 
     (4,881,095)
  
    Changes in operating assets and liabilities: 

    Prepaid expenses 
     24,020 
  
    Accounts payable and accrued expenses 
     23,633 
  
    Due to Sponsor 
     60,000 
  
    Net cash used in operating activities 
     (227,705)

    Net Change in Cash 
     (227,705)
  
    Cash - Beginning of period 
     949,366 
  
    Cash - End of period 
    $721,661 

The accompanying notes are an integral part of
the unaudited condensed financial statements.

4

JACKSON ACQUISITION COMPANY II

NOTES TO CONDENSED FINANCIAL STATEMENTS

JUNE 30, 2025

(UNAUDITED)

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Jackson Acquisition Company II (the “Company”)
is a blank check company incorporated as a Cayman Islands exempted company on September 11, 2024. The Company was incorporated for
the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with
one or more businesses (“Business Combination”).

While the Company may pursue an initial Business
Combination target in any industry or geographic location, the Company intends to focus its search for a target business by concentrating
its efforts in identifying high-quality businesses with a focus on healthcare services, healthcare technology, or otherwise focused on
the healthcare industry. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the
risks associated with early stage and emerging growth companies.

As of June 30, 2025, the Company had not commenced
any operations. All activity for the period from September 11, 2024 (inception) through June 30,